A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Public ClinicalTrials.gov record NCT06624670. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-centre, Randomised, Placebo-controlled, Double-blind, Parallel-group Trial to Evaluate Safety and Efficacy of Spesolimab (BI 655130) in Adult Patients With Ulcerative Pyoderma Gangrenosum (PG) Who Require Systemic Therapy
Study identification
- NCT ID
- NCT06624670
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Interventions
- Placebo matching to spesolimab Drug
- Prednisolone Drug
- Prednisone Drug
- Spesolimab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 3, 2025
- Primary completion
- Nov 11, 2027
- Completion
- Aug 18, 2028
- Last update posted
- May 12, 2026
2025 – 2028
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | Recruiting |
| Medical Dermatology Specialists Phoenix | Phoenix | Arizona | 85006 | Recruiting |
| University of California Irvine | Irvine | California | 92697 | Recruiting |
| University of Miami | Miami | Florida | 33136 | Recruiting |
| University of South Florida | Tampa | Florida | 33612 | Recruiting |
| Ada West Research | Meridian | Idaho | 83646 | Not yet recruiting |
| Dawes Fretzin Clinical Research Group, LLC-Indianapolis -68995 | Indianapolis | Indiana | 46250 | Recruiting |
| Tulane University Hospital and Clinic | New Orleans | Louisiana | 70112 | Not yet recruiting |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Recruiting |
| University of Michigan | Ann Arbor | Michigan | 48109 | Recruiting |
| Dartmouth Hitchcock Clinics Heater Road | Lebanon | New Hampshire | 03766 | Recruiting |
| Dermatology at Lake Success | Lake Success | New York | 11042 | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Recruiting |
| Red River Research Partners, LLC | Fargo | North Dakota | 58103 | Recruiting |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Not yet recruiting |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | Recruiting |
| Oregon Health and Sciences University | Portland | Oregon | 97239 | Not yet recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Epiphany Dermatology | Lewisville | Texas | 75056 | Recruiting |
| University of Utah Health MidValley Dermatology | Murray | Utah | 84107 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 77 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06624670, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06624670 live on ClinicalTrials.gov.